Evaluation of new biomarkers of thrombosis

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

The assessment of thrombosis requires the holistic evaluation of in-vivo coagulation including total clot formation. Unfortunately, current tests only evaluate the time to the start of clot formation. Experimental biomarkers such us thrombin generation, endothelial markers, microparticles and microRNA may provide a better framework for evaluating thrombotic risk. Translation of these markers to clinical use requires understanding of their expression in the normal population and assessment of their ability to detect thrombotic disorders.

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2016

Funding Scheme: Postgraduate Scholarships

Funding Amount: $108,889.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cardiovascular | cardiovascular risk factors | haematology | haemostasis | thrombosis